Phase II study of nab-paclitaxel and bevacizumab as first-line therapy for patients with unresectable stage III and IV melanoma (Q46951033)
Jump to navigation
Jump to search
scientific article published in February 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of nab-paclitaxel and bevacizumab as first-line therapy for patients with unresectable stage III and IV melanoma |
scientific article published in February 2015 |
Statements
1 reference
Phase II study of nab-paclitaxel and bevacizumab as first-line therapy for patients with unresectable stage III and IV melanoma (English)
1 reference
Lynn E Spitler
1 reference
Peter Boasberg
1 reference
Steven O'Day
1 reference
Omid Hamid
1 reference
Scott Cruickshank
1 reference
Shane Mesko
1 reference
Robert W Weber
1 reference
1 February 2015
1 reference
38
1 reference
1
1 reference
61-67
1 reference